Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?-Reference-Cited by-同舟云学术

Cefoperazone/sulbactam: New composites against multiresistant gram negative bacteria?

Published:2021-03 Issue: Volume:88 Page:104707
ISSN:1567-1348
Container-title:Infection, Genetics and Evolution
language:en
Short-container-title:Infection, Genetics and Evolution

Author:

Ku Yee-Huang,Yu Wen-Liang

Publisher

Elsevier BV

Subject

Infectious Diseases,Microbiology (medical),Genetics,Molecular Biology,Ecology, Evolution, Behavior and Systematics,Microbiology

Reference80 articles.

1. Activity of beta-lactam beta-lactamase inhibitor combinations against extended spectrum Beta-lactamase producing Enterobacteriaceae in urinary isolates;Afridi;J. Coll. Physicians Surg. Pak.,2012

2. Sulbactam-containing beta-lactamase inhibitor combinations;Akova;Clin. Microbiol. Infect.,2008

3. Epidemiology of bloodstream infections caused by Escherichia coli and Klebsiella pneumoniae that are piperacillin-tazobactam-nonsusceptible but ceftriaxone-susceptible;Baker;Open Forum Infect. Dis.,2018

4. Criteria for disk susceptibility tests and quality control guidelines for the cefoperazone-sulbactam combination;Barry;J. Clin. Microbiol.,1988

5. Role of beta-lactamase inhibitors in enterobacterial isolates producing extended-spectrum beta-lactamases;Bhattacharjee;J. Antimicrob. Chemother.,2008

Cited by 16 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Machine learning and feature extraction for rapid antimicrobial resistance prediction of Acinetobacter baumannii from whole-genome sequencing data;Frontiers in Microbiology;2024-01-11

2. Development and validation of a nomogram for predicting cefoperazone/sulbactam-induced hypoprothrombinaemia in Hospitalized adult patients;PLOS ONE;2023-09-21

3. An integrated microfluidic chip-mass spectrometry system for rapid antimicrobial resistance analysis of bacteria producing β-lactamases;Chinese Chemical Letters;2023-05

4. Assessment of Effective Antimicrobial Regimens and Mortality-Related Risk Factors for Bloodstream Infections Caused by Carbapenem-Resistant Acinetobacter baumannii;Infection and Drug Resistance;2023-05

5. Efficacy of Cefoperazone Sulbactam in Patients with Acinetobacter Infections: A Systematic Review of the Literature;Antibiotics;2023-03-15